AVITA Medical to Announce Second Quarter 2026 Financial Results

VALENCIA, Calif. – July 14, 2026 – AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) announced today that it will report its second quarter 2026 financial results after the close of U.S. financial markets on Thursday, August 6, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights. AVITA Medical focuses on advanced wound care, with technologies like the FDA-approved RECELL system, which uses a patient's own skin cells for treatment. The company also offers other wound care products in the U.S. and international markets. Companies in the healthcare technology sector regularly issue financial results to provide investors with insight into their economic performance and development. These announcements are crucial for assessing a company's valuation and future prospects. Access to the conference call and webcast will be available via registration on the company's investor relations website, where a replay will also be posted.